Pharmacologic approaches to therapy for vasovagal syncope

作     者：Calkins, H 

作者机构：Johns Hopkins Univ Dept Med Baltimore MD USA Johns Hopkins Univ Dept Pediat Baltimore MD USA 

出 版 物：《AMERICAN JOURNAL OF CARDIOLOGY》 (美国心脏病学杂志)

年 卷 期：1999年第84卷第8A期

页      面：20Q-25Q页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：阿替洛尔/治疗应用 氟氢可的松/治疗应用 米多君/治疗应用 帕罗西汀/治疗应用 晕厥 血管迷走神经性/药物疗法 晕厥 血管迷走神经性/病因学 治疗结果 人类 

摘      要：Vasovagal syncope is a common disorder of autonomic cardiovascular regulation, Many pharmacologic agents have been proposed as effective in the management of this condition based on nonrandomized clinical trials, Notably, only 3 agents-atenolol, midodrine, and paroxetine- have demonstrated efficacy in the treatment of vasovagal syncope in at least 1 prospective, randomized, placebo-controlled clinical trial. Other therapies commonly used in treating syncope include increased salt and fluid intake and fludrocortisone, In this review, we provide a summary of currently available data that support or question the use of various pharmacologic agents for treatment of vasovagal syncope, (C) 1999 by Excerpta Medica, Inc.